Volume No. :   8

Issue No. :  4

Year :  2018

ISSN Print :  2231-5705

ISSN Online :  2231-5713


Allready Registrered
Click to Login

Design and Development of Solid Self-Microemulsifying Drug Delivery of Gefitinib

Address:   Ghadge Dhairyasheel, Yadav Adhikrao, Gharge Varsha*
Gourishankar Institute of Pharmaceutical Education and Research, Limb, Satara, Maharashtra, India-415015
*Corresponding Author
DOI No: 10.5958/2231-5713.2018.00031.4

Objective: Solid self-microemulsifying drug delivery system (SMEDDS) of Gefitinib was aimed at overcoming the problems of poor solubility and bioavailability. Methodology: The formulation strategy included selection of oil phase based on saturated solubility studies and surfactant and co-surfactant screening on the basis of their emulsification ability. Ternary phase diagrams were constructed to identify the self-emulsifying region using a dilution method. The prepared formulations of SMEDDS were evaluated for their drug content, loading efficiency, morphology, globule size determination. Results: The formulation containing gefitinib (25 mg), oleic acid (20% w/w), tween 80 (30% w/w), propylene glycol (10% w/w) and water (40% w/w) was concluded to be optimized. The optimized SMEDDS and solid-SMEDDS exhibited 84.4 % in vitro drug release up to 60 min, which was significantly higher than that of the pure drug. Solid-SMEDDS may be considered as a better solid dosage form as solidified formulations are more ideal than liquid ones in terms of its stability. Conclusion: These results suggest the potential use of SMEDDS and solid-SMEDDS to improve the dissolution and hence oral bioavailability of poorly water-soluble drugs like Gefitinib through oral route.
Gefitinib, solid-SMEDDS, Ternary phase diagrams, in vitro drug release,). In-Vitro Anticancer Activity Study
Ghadge Dhairyasheel, Yadav Adhikrao, Gharge Varsha. Design and Development of Solid Self-Microemulsifying Drug Delivery of Gefitinib. Asian J. Pharm. Tech. 2018; 8 (4):193-199.
[View HTML]     

Visitor's No. :   220225